217 related articles for article (PubMed ID: 2755320)
1. The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver.
Sorrentino D; Weisiger RA; Bass NM; Licko V
Lipids; 1989 May; 24(5):438-42. PubMed ID: 2755320
[TBL] [Abstract][Full Text] [Related]
2. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
Foliot A; Touchard D; Celier C
Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in sulfobromophthalein-glutathione transport by perfused rat liver.
Sorrentino D; Licko V; Weisiger RA
Biochem Pharmacol; 1988 Aug; 37(16):3119-26. PubMed ID: 3401243
[TBL] [Abstract][Full Text] [Related]
4. Does Z-protein have a role in transport of bilirubin and bromosulfophthalein by isolated perfused rat liver?
Theilmann L; Stollman YR; Arias IM; Wolkoff AW
Hepatology; 1984; 4(5):923-6. PubMed ID: 6384000
[TBL] [Abstract][Full Text] [Related]
5. Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate.
Luxon BA; Milliano MT; Weisiger RA
Biochim Biophys Acta; 2000 Sep; 1487(2-3):309-18. PubMed ID: 11018482
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate.
Foliot A; Touchard D; Mallet L
Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598
[TBL] [Abstract][Full Text] [Related]
7. Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats.
Bass NM; Barker ME; Manning JA; Jones AL; Ockner RK
Hepatology; 1989 Jan; 9(1):12-21. PubMed ID: 2642289
[TBL] [Abstract][Full Text] [Related]
8. Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione.
Sorrentino D; Licko V; Weisiger RA; Alpini G; Berk PD
Biochem Biophys Res Commun; 1987 Dec; 149(3):921-6. PubMed ID: 3426617
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites.
Hung DY; Burczynski FJ; Chang P; Lewis A; Masci PP; Siebert GA; Anissimov YG; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G423-33. PubMed ID: 12444013
[TBL] [Abstract][Full Text] [Related]
10. The sinusoidal efflux of dibromosulfophthalein from rat liver is stimulated by albumin, ligandin and fatty acid binding protein but not by other dibromosulfophthalein binding proteins.
Nijssen HM; Pijning T; Proost JH; Meijer DK; Groothuis GM
J Hepatol; 1994 Jul; 21(1):29-36. PubMed ID: 7525696
[TBL] [Abstract][Full Text] [Related]
11. The peroxisomal proliferator clofibrate enhances the hepatic cytoplasmic movement of fatty acids in rats.
Milliano MT; Luxon BA
Hepatology; 2001 Feb; 33(2):413-8. PubMed ID: 11172343
[TBL] [Abstract][Full Text] [Related]
12. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver?
Inoue M; Okajima K; Nagase S; Morino Y
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7654-8. PubMed ID: 6584879
[TBL] [Abstract][Full Text] [Related]
13. Effect of peroxisome proliferators on glutathione-dependent sulphobromophthalein excretion.
James SI; Ahokas JT
Xenobiotica; 1992 Dec; 22(12):1425-32. PubMed ID: 1494887
[TBL] [Abstract][Full Text] [Related]
14. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
[TBL] [Abstract][Full Text] [Related]
15. Carrier-mediated uptake and excretion of bromosulfophthalein-glutathione in perfused rat liver: a multiple indicator dilution study.
Geng WP; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1995 Oct; 22(4 Pt 1):1188-207. PubMed ID: 7557871
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
Yam J; Reeves M; Roberts RJ
J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
[TBL] [Abstract][Full Text] [Related]
17. Relationship of carbon tetrachloride-induced alterations of ligandin and Z protein to sulfobromophthalein transport in rat liver.
Hatta S; Ohshika H; Tanaka M
J Toxicol Sci; 1981 Aug; 6(3):177-89. PubMed ID: 7299855
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate.
Bass NM; Manning JA; Ockner RK; Gordon JI; Seetharam S; Alpers DH
J Biol Chem; 1985 Feb; 260(3):1432-6. PubMed ID: 3968078
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutathione efflux in the perfused rat liver and isolated hepatocytes by organic anions and bilirubin. Kinetics, sidedness, and molecular forms.
Ookhtens M; Lyon I; Fernandez-Checa J; Kaplowitz N
J Clin Invest; 1988 Aug; 82(2):608-16. PubMed ID: 3403719
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic fatty acid binding protein enhances rat hepatocyte [3H]palmitate uptake.
Burczynski FJ; Fandrey S; Wang G; Pavletic PA; Gong Y
Can J Physiol Pharmacol; 1999 Nov; 77(11):896-901. PubMed ID: 10593663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
